1 / 22

Schering-Plough

Schering-Plough Marketing Strategy Recommendation and Expansion Analysis Team Acci ó n: Beth, Diane, Kevin, Don, and Felix April 2006. Schering-Plough. SWOT Analysis. Corporate Objectives. Provide a steady flow of medicines and services Earn trust Establish long-term relationships

jimbo
Download Presentation

Schering-Plough

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Schering-PloughMarketing Strategy Recommendation and Expansion Analysis Team Acción:Beth, Diane, Kevin, Don, and FelixApril 2006 Schering-Plough

  2. SWOT Analysis

  3. Corporate Objectives • Provide a steady flow of medicines and services • Earn trust • Establish long-term relationships • Concentrated focus on research

  4. Strengths and Competitive Advantages • Financial • Business grew in spite of FDA consent decree • American Jobs Creation Act of 2004 • Technical • Remicade, Vytorin, Zetia each > $1B in 2005 • R&D – triple-digit pipeline growth • HR • New Executive Team • Corporate philosophy

  5. Synergy • Methods • Acquisitions • Partnerships • Advantages • Global • IP • Share the risk

  6. Path to achieve growth over time Continue current momentum People Products Processes Time Line

  7. Summary and Recommendations Growth Strategies

  8. Summary and Recommendations Five-Year Plan

  9. Summary of Marketing Recommendations

  10. Examination of Expansion Office Proposal A small part of the solution? Schering-Plough in Bogotá? The purpose of this project is to determine the feasibility over five years for an expansion division of Schering-Plough Animal Health into Bogotá, Colombia. Products initially offered would be limited to pharmaceutical services for bovine and large animals.

  11. Examination of Expansion Proposal Assumptions A man was injured jumping over this waterfall. Prior to the plunge, the man yelled, "Watch this!" How accurate where his assumptions? http://www.wsbtv.com/news/8819343/detail.html

  12. Examination of Expansion Proposal Assumptions made for financial calculations • Financial Assumptions • Average of two WACCs is an acceptable compromise. • A 5% risk premium for Colombia is reasonable. • Analysts’ call of 21% growth per annum for the next 5 years is appropriate. • 3.75 million heads of cattle can be added to the Schering-Plough customer base readily. • Historical cost trends in Bogotá will be predictive of future trends. • For Depreciation Tables, MACRS Data Used • Tax rate will be the US rate 43% (vs. Colombia’s 35% rate) • Inflation will result in • 2% increase in sales prices • 2% increase in variable costs • 4.9% increase in fixed costs

  13. Examination of Expansion Proposal CONT. Assumptions for financials • Operating Cost Assumptions • Obtain a 3-year lease, followed by 10% increase upon renewal; applies to both monthly lease and admin costs • Salaries will increase an average of 4.9% per year • No significant air freight disruptions will occur between U.S. and Colombia. • No unexpected, radical changes in fuel and utility market • Product Assumptions • All 21 initial cattle products will be legal and have a use in Colombia. • 12 additional SPAH products can be added each year • 15% market share in year 1 is obtainable • 12% sales growth in years 2-5 plausible

  14. Cost of Financing Expansion Proposal SGP Cost of Capital Most of the assumptions concern these values, which are used in calculating WACC and other financials.

  15. Cost of Financing Expansion Proposal WACC Development

  16. Proposed Products in South American Line Preventives & Treatments • Others: • Tri Merit (verification and tracking program) • Ralgro Implants • Estrumate • Bo-Se • Mu-Se • Vital E • Rabdomun • Centurion • Atroban • Saber • Levosal • Piliguard • Guardian • Colostrx • Banamine • Electroid • Siteguard • Covexin

  17. Operational Costs of Expansion Proposal Proposed Location: Size, including office spaces: 2225 m2. Monthly rent: US $8,700 Admin costs: US $450 Salaries

  18. Scenario Analysis of Expansion Proposal Scenarios for Base Case, Worst Case and Best Case THE GOOD THE BAD Outcome is predictable and almost certain. Distinguishing between, bad, worse and worst. THE UGLY

  19. Making the Decision on the Expansion Proposal Fiscal Responsibility Indicates SGP Animal Health Bogotá Not Viable • Financials • NPV, IRR, MIRR all agree • Better use of SGP debt • Alternatives • Other S. American Locations • Different Product Mix • Larger Scale • Partner with Pfizer

  20. Questions & Answers

  21. References Anonymous. 2006. Schering-Plough Meets FDA Deadline for CGMP Improvements. Pharmaceutical Technology, February, Vol. 30, Iss. 2, pg. 24. Editor. 2006. Compound from Pharmacopeia Collaboration Shows Clinical Activity for COPD in Phase I Trial. Health Insurance Law Weekly, 16 April, pg. 100. Editor. 2006. Schering Plough Announces Changes in Executive Finance Positions. Healthcare Mergers, Acquisitions & Ventures Week, 15 April, pg. 101. Editor. 2006. Schering-Plough targets Europe, Latin America, Asia-Pacific With new Appointments, Actions. Obesity, Fitness & Wellness Week, 8 April, pg. 220.

  22. References Editor. 2006. Drug Makers Agree to Share Test Data. The Wall Street Journal, 17 March, pg. A1. Editor. 2006. Michael D. Boyd Named VP of International Public Affairs by Global Healthcare Company. Health Insurance Week, 5 February, pg. 98. Iskowitz, Marc. 2006. While ED Ads Take a Direct Approach. Medical Marketing and Media, February, Vol. 41, Iss. 2, pg. 11. Lublin, Joann and Thurm, Scott. 2006. How Companies Calculate Odds in Buyout Offers. The Wall Street Journal, 27 March, pg. B1.

More Related